Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
Diletta Magini, Cinzia Giovani, Simona Mangiavacchi, et al.
PLoS ONE (2016) Vol. 11, Iss. 8, pp. e0161193-e0161193
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

mRNA vaccines — a new era in vaccinology
Norbert Pardi, Michael J. Hogan, Frederick Porter, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 4, pp. 261-279
Open Access | Times Cited: 3551
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Namit Chaudhary, Drew Weissman, Kathryn A. Whitehead
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 817-838
Open Access | Times Cited: 969
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Jonathan D. Finn, Amy Smith, Mihir Patel, et al.
Cell Reports (2018) Vol. 22, Iss. 9, pp. 2227-2235
Open Access | Times Cited: 679
Advances in mRNA Vaccines for Infectious Diseases
Cuiling Zhang, Giulietta Maruggi, Hu Shan, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 606
New Vaccine Technologies to Combat Outbreak Situations
Susanne Rauch, Edith Jasny, Kim E. Schmidt, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 553
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Giulietta Maruggi, Cuiling Zhang, Junwei Li, et al.
Molecular Therapy (2019) Vol. 27, Iss. 4, pp. 757-772
Open Access | Times Cited: 414
Self-amplifying RNA vaccines for infectious diseases
Kristie Bloom, Fiona T. van den Berg, Patrick Arbuthnot
Gene Therapy (2020) Vol. 28, Iss. 3-4, pp. 117-129
Open Access | Times Cited: 341
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
Alec W. Freyn, Jamile Ramos da Silva, Victoria Rosado, et al.
Molecular Therapy (2020) Vol. 28, Iss. 7, pp. 1569-1584
Open Access | Times Cited: 252
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Norbert Pardi, Kaela Parkhouse, Ericka Kirkpatrick, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 244
Mechanism of action of mRNA-based vaccines
Carlo Iavarone, Derek T. O’Hagan, Dong Yü, et al.
Expert Review of Vaccines (2017) Vol. 16, Iss. 9, pp. 871-881
Closed Access | Times Cited: 208
An Update on Self-Amplifying mRNA Vaccine Development
Anna K. Blakney, Shell Ip, Andrew J. Geall
Vaccines (2021) Vol. 9, Iss. 2, pp. 97-97
Open Access | Times Cited: 195
Formulation and Delivery Technologies for mRNA Vaccines
Chunxi Zeng, Chengxiang Zhang, Patrick Walker, et al.
Current topics in microbiology and immunology (2020), pp. 71-110
Open Access | Times Cited: 179
Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
Basmah N. Aldosari, Iman M. Alfagih, Alanood S. Almurshedi
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 206-206
Open Access | Times Cited: 174
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell
Journal of Controlled Release (2018) Vol. 292, pp. 256-276
Open Access | Times Cited: 173
Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Majed Ghattas, Garima Dwivedi, Marc Lavertu, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1490-1490
Open Access | Times Cited: 122
Milk-Derived Exosomes and Metabolic Regulation
Janos Zempleni, Sonal Sukreet, Fang Zhou, et al.
Annual Review of Animal Biosciences (2018) Vol. 7, Iss. 1, pp. 245-262
Open Access | Times Cited: 147
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies
Maria Trovato, Rossella Sartorius, Luciana D’Apice, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 124
Novel Platforms for the Development of a Universal Influenza Vaccine
Arun Kumar, Trine Sundebo Meldgaard, Sylvie Bertholet
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 96
Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
Leroy Versteeg, Mashal M. Almutairi, Peter J. Hotez, et al.
Vaccines (2019) Vol. 7, Iss. 4, pp. 122-122
Open Access | Times Cited: 83
Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm
Wei Wang, Shuo Feng, Zhuyifan Ye, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 6, pp. 2950-2962
Open Access | Times Cited: 81
Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections
Cynthia Calzas, Christophe Chevalier
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 78
A new generation of vaccines based on alphavirus self-amplifying RNA
María Cristina Ballesteros-Briones, Noelia Silva-Pilipich, Guillermo Herrador, et al.
Current Opinion in Virology (2020) Vol. 44, pp. 145-153
Open Access | Times Cited: 70
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2150-2150
Open Access | Times Cited: 64
Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy
Chi Zhang, Yifan Ma, Jingjing Zhang, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1943-1943
Open Access | Times Cited: 57
Progress towards the Development of a Universal Influenza Vaccine
Wen-Chien Wang, Ekramy E. Sayedahmed, Suryaprakash Sambhara, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1684-1684
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top